Back to search
Tetanus-diphtheria-acellular Pertussis (Tdap)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Tetanus-diphtheria-acellular Pertussis (Tdap) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Tetanus-diphtheria-acellular Pertussis (Tdap) trials you may qualify forThe goal of this InTroDuce-Programme interventional trial aims to test whether a web-based educational program can improve pregnant women's knowledge about Infl…
The goal of this clinical trial is to learn if the RSV vaccine (protects against respiratory syncytial virus) and Tdap vaccine (protects against pertussis) are…
This clinical trial is conducted in two parts. Part One employs a randomized, partially blinded, dose-escalation, partially active-controlled design. Part Two u…
This clinical trial consists of two parts: Part 1, which explores safety, and Part 2, which examines both safety and efficacy (immunogenicity). Part 1 is a sing…
The goal of this randomized control trial is to assess if prenatal vaccine education and in-office vaccination administration for non-birthing partners of pregn…
The purpose of this study is to evaluate the safety and immunogenicity of the DTaP in 3-month-old infants.
This study is designed to monitor the safety of Boostagen® after it has been approved for use in Thailand. The study follows people who receive the vaccine in r…
This study is designed to assess the immunogenicity and safety of DTaP vaccine (BK1301) as a booster dose in adolescents. The purposes of this study are as fol…
Recombinant acellular pertussis vaccines containing genetically detoxified Pertussis Toxin (PTgen) have been used for booster immunisation in children, adolesce…